Federated Hermes’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.91M | Buy |
82,468
+21,041
| +34% | +$2.16M | 0.01% | 755 |
|
|
2026
Q1 | $6.71M | Buy |
61,427
+2,578
| +4% | +$246K | 0.01% | 744 |
|
|
2025
Q4 | $4.77M | Buy |
58,849
+18,303
| +45% | +$1.58M | 0.01% | 788 |
|
|
2025
Q3 | $3.55M | Buy |
40,546
+887
| +2% | +$79.2K | 0.01% | 804 |
|
|
2025
Q2 | $3.29M | Buy |
39,659
+155
| +0.4% | +$13K | 0.01% | 833 |
|
|
2025
Q1 | $3.31M | Buy |
39,504
+518
| +1% | +$48.2K | 0.01% | 812 |
|
|
2024
Q4 | $3.59M | Buy |
38,986
+38,884
| +38,122% | +$3.74M | 0.01% | 794 |
|
|
2024
Q3 | $9.47K | Buy |
102
+41
| +67% | +$3.55K | ﹤0.01% | 1810 |
|
|
2024
Q2 | $5.02K | Buy |
61
+27
| +79% | +$1.98K | ﹤0.01% | 1839 |
|
|
2024
Q1 | $2.26K | Buy |
34
+27
| +386% | +$1.67K | ﹤0.01% | 1911 |
|
|
2023
Q4 | $397 | Sell |
7
-175
| -96% | -$9.17K | ﹤0.01% | 2019 |
|
|
2023
Q3 | $9.91K | Buy |
182
+26
| +17% | +$1.54K | ﹤0.01% | 1829 |
|
|
2023
Q2 | $10.5K | Sell |
156
-137
| -47% | -$8.36K | ﹤0.01% | 1844 |
|
|
2023
Q1 | $15.1K | Buy |
293
+289
| +7,225% | +$14K | ﹤0.01% | 1838 |
|
|
2022
Q4 | $184 | Sell |
4
-140
| -97% | -$6.55K | ﹤0.01% | 2123 |
|
|
2022
Q3 | $7K | Sell |
144
-99
| -41% | -$4.95K | ﹤0.01% | 1865 |
|
|
2022
Q2 | $11K | Sell |
243
-123,925
| -100% | -$5.54M | ﹤0.01% | 1820 |
|
|
2022
Q1 | $5.77M | Sell |
124,168
-5,568
| -4% | -$249K | 0.01% | 745 |
|
|
2021
Q4 | $6.52M | Sell |
129,736
-231
| -0.2% | -$11.9K | 0.01% | 754 |
|
|
2021
Q3 | $6.9M | Buy |
129,967
+3,377
| +3% | +$190K | 0.01% | 751 |
|
|
2021
Q2 | $7.72M | Buy |
126,590
+19
| +0% | +$1.01K | 0.01% | 727 |
|
|
2021
Q1 | $6.17M | Buy |
126,571
+7,561
| +6% | +$354K | 0.01% | 785 |
|
|
2020
Q4 | $4.82M | Buy |
119,010
+55
| +0% | +$1.97K | 0.01% | 818 |
|
|
2020
Q3 | $3.87M | Sell |
118,955
-5,848
| -5% | -$176K | 0.01% | 789 |
|
|
2020
Q2 | $3.29M | Sell |
124,803
-58,065
| -32% | -$1.52M | 0.01% | 828 |
|
|
2020
Q1 | $4.56M | Buy |
182,868
+5,512
| +3% | +$170K | 0.01% | 649 |
|
|
2019
Q4 | $6.38M | Buy |
177,356
+55,319
| +45% | +$1.91M | 0.01% | 708 |
|
|
2019
Q3 | $4.17M | Buy |
122,037
+121,085
| +12,719% | +$3.87M | 0.01% | 816 |
|
|
2019
Q2 | $27K | Buy |
952
+127
| +15% | +$3.53K | ﹤0.01% | 1764 |
|
|
2019
Q1 | $26K | Buy |
825
+317
| +62% | +$8.46K | ﹤0.01% | 1737 |
|
|
2018
Q4 | $12K | Sell |
508
-14,817
| -97% | -$405K | ﹤0.01% | 1848 |
|
|
2018
Q3 | $594K | Sell |
15,325
-29,273
| -66% | -$1.05M | ﹤0.01% | 1457 |
|
|
2018
Q2 | $1.49M | Sell |
44,598
-11,314
| -20% | -$403K | ﹤0.01% | 1142 |
|
|
2018
Q1 | $2.03M | Sell |
55,912
-43,247
| -44% | -$1.5M | 0.01% | 951 |
|
|
2017
Q4 | $3.16M | Sell |
99,159
-63,781
| -39% | -$2.18M | 0.01% | 762 |
|
|
2017
Q3 | $6.1M | Sell |
162,940
-5,738
| -3% | -$195K | 0.02% | 509 |
|
|
2017
Q2 | $5.27M | Buy |
168,678
+5,173
| +3% | +$149K | 0.02% | 561 |
|
|
2017
Q1 | $4.03M | Buy |
163,505
+6,082
| +4% | +$143K | 0.01% | 655 |
|
|
2016
Q4 | $3.99M | Buy |
157,423
+57,131
| +57% | +$1.27M | 0.01% | 620 |
|
|
2016
Q3 | $1.99M | Buy |
100,292
+41,836
| +72% | +$731K | 0.01% | 850 |
|
|
2016
Q2 | $834K | Buy |
58,456
+653
| +1% | +$9.98K | ﹤0.01% | 1146 |
|
|
2016
Q1 | $897K | Buy |
57,803
+5,396
| +10% | +$77.4K | ﹤0.01% | 1107 |
|
|
2015
Q4 | $904K | Buy |
52,407
+20,064
| +62% | +$290K | ﹤0.01% | 1130 |
|
|
2015
Q3 | $394K | Buy |
+32,343
| New | +$415K | ﹤0.01% | 1350 |
|
Other funds holding LMAT
CCA
CAM
CCM
Federated Hermes's LMAT Position: Q2 2026 in Review
Federated Hermes increased its LeMaitre Vascular (LMAT) stake by 34% in Q2 2026, buying an estimated $2.16M and bringing the position to 82,468 shares worth $7.91M. The position accounts for 0.01% of the portfolio, ranked #755.
Federated Hermes first reported a position in LMAT in Q3 2015 and has held it in 44 quarters since. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Federated Hermes held 82,468 shares of LeMaitre Vascular worth $7.91M as of Q2 2026.
- Federated Hermes bought 21,041 LeMaitre Vascular shares in Q2 2026, an estimated $2.16M.
- LeMaitre Vascular made up 0.01% of Federated Hermes's portfolio in Q2 2026, its #755 holding.
- Federated Hermes first reported a position in LeMaitre Vascular in Q3 2015 and has held it in 44 quarters since.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.